Table 3.
Pulmonary TB (n = 133) | Non-TB CAP (n = 133) | p value | NPV | PPV | |
---|---|---|---|---|---|
Emphysematous lesions | 38 (29) | 30 (23) | 0.261 | 0.480 | 0.441 |
GGO | 72 (54) | 110 (83) | < 0.001 | 0.274 | 0.396 |
Airspace consolidation | 109 (82) | 105 (79) | 0.536 | 0.538 | 0.509 |
Reticular shadow | 8 (6) | 16 (12) | 0.087 | 0.483 | 0.333 |
Centrilobular nodule | 93 (70) | 37 (28) | < 0.001 | 0.706 | 0.715 |
Air bronchogram | 80 (60) | 21 (16) | < 0.001 | 0.679 | 0.792 |
Cavity | 56 (42) | 2 (2) | < 0.001 | 0.630 | 0.966 |
Bronchial wall thickening | 31 (23) | 58 (44) | < 0.001 | 0.424 | 0.348 |
Bronchiectasis | 30 (23) | 31 (23) | 0.884 | 0.498 | 0.492 |
Pleural effusion | 46 (35) | 29 (22) | 0.021 | 0.545 | 0.613 |
Enlargement of mediastinum and/or hilar lymph node | 52 (39) | 31 (23) | 0.005 | 0.557 | 0.627 |
Distributions of GGO and/or consolidation | |||||
Number of lobe involvements | 2 (1–4) | 3 (2–5) | 0.002 | ||
Bilateral lungs | 64 (48) | 96 (72) | < 0.001 | 0.349 | 0.400 |
Right lung | 96 (72) | 121 (91) | < 0.001 | 0.245 | 0.442 |
Left lung | 83 (62) | 113 (85) | < 0.001 | 0.286 | 0.423 |
Upper lobes | 81 (61) | 77 (58) | 0.617 | 0.519 | 0.513 |
Middle lobes | 80 (60) | 93 (70) | 0.095 | 0.430 | 0.462 |
Lower lobes | 79 (59) | 114 (86) | < 0.001 | 0.260 | 0.409 |
Data are presented as number (%).
CAP community-acquired pneumonia, TB tuberculosis, NPV negative predictive value, PPV positive predictive value, GGO ground-glass opacities.